Treatment for MS typically involves a combination of medications that include interferon-beta (IFNβ), such as glatiramer acetate, fingolimod, dimethyl fumarate, and others to either prevent immune cells from entering the brain or inhibit their activities. This evidence concerns the gene IFNB1 and myeloid sarcoma.